Global life sciences company, Thermo Fisher Scientific, is growing its operation in Cork and creating 36 science, engineering and operations positions.
Thermo Fisher Scientific acquired the active pharmaceutical ingredient manufacturing facility from GlaxoSmithKline's in October 2019.
The sale saw the ownership of GSK’s Cork manufacturing site, including all facilities, business operations and commercial manufacturing and R&D employees transfer to Thermo Fisher Scientific.
The Cork site is a contract pharmaceutical manufacturing facility and part of the company's Pharma Services business. It offers drug substance, drug development, clinical trials, drug product and viral vector development and manufacturing solutions to companies of all sizes.
These new roles are for experienced professionals in the areas of science, engineering and operations, bringing the Thermo Fisher Scientific Cork workforce to over 450 employees.
Siobhan Creedon, Site Technical Lead said the ambition for the site is to grow the business to enable many pharmaceutical and life sciences companies make the world healthier by supplying active pharmaceutical ingredients for a range of disease areas.
"The announcement of these new positions marks an exciting time for Thermo Fisher Scientific’s Cork site, as we take on new projects with our clients, supporting them from product development right through to commercial manufacture. It is a fantastic opportunity for the right candidates."
